Randomized Comparison of Enoxaparin, a Low-Molecular-Weight Heparin, With Unfractionated Heparin Adjunctive to Recombinant Tissue Plasminogen Activator Thrombolysis and Aspirin: Second Trial of Heparin and Aspirin Reperfusion Therapy - HART II

Description:

The second trial of Heparin and Aspirin Reperfusion Therapy (HART II) was a randomized comparison of enoxaparin, a low-molecular-weight heparin, with unfractionated heparin (UFH) adjunctive to recombinant tissue plasminogen activator thrombolysis and aspirin.